What is the recommended dosage and treatment plan for Antabuse (disulfiram) in patients with chronic alcoholism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Disulfiram (Antabuse) Dosage and Treatment Plan for Chronic Alcoholism

Disulfiram should be administered at an initial dose of 500 mg daily for 1-2 weeks, followed by a maintenance dose of 250 mg daily (range 125-500 mg), and should only be used in alcohol-dependent patients without advanced alcoholic liver disease due to potential hepatotoxicity. 1

Initial Assessment and Preparation

  • Ensure patient has abstained from alcohol for at least 12 hours before starting disulfiram
  • Verify patient does not have advanced alcoholic liver disease (ALD) as disulfiram is contraindicated in these patients 2
  • Confirm normal liver function tests before initiating therapy
  • Educate patient thoroughly about:
    • The disulfiram-alcohol reaction (flushing, headache, nausea, vomiting, hypotension)
    • The importance of avoiding all alcohol-containing products
    • The need for medication adherence

Dosing Protocol

Initial Phase

  • 500 mg daily in a single dose for 1-2 weeks 1
  • May be taken in the morning or at bedtime if sedation occurs
  • Dose can be adjusted downward if sedative effects are problematic

Maintenance Phase

  • 250 mg daily (range 125-500 mg) 1
  • Maximum dose should not exceed 500 mg daily
  • Uninterrupted daily administration must continue until patient is fully recovered socially

Duration of Therapy

  • Long-term treatment is often necessary
  • Maintenance therapy may be required for months or even years depending on individual patient needs 1
  • Regular follow-up is essential to monitor compliance and efficacy

Monitoring and Follow-up

  • Regular liver function tests to monitor for hepatotoxicity
  • Verify medication compliance (preferably with supervised administration)
  • Monitor for cardiac, hepatic, and neurologic toxicity 3
  • Potassium levels should be monitored, particularly in patients on digitalis 1

Important Considerations

  • Disulfiram is contraindicated in patients with advanced ALD due to potential side effects 2
  • The medication should never be used alone but as part of a comprehensive treatment program
  • Supervised administration significantly improves compliance and outcomes 4
  • Disulfiram may help reduce drinking frequency after relapse but does not necessarily enhance continuous abstinence 5

Patient Selection Criteria

Disulfiram is most appropriate for:

  • Patients without advanced liver disease
  • Motivated individuals who understand and accept the consequences
  • Patients who have failed with less structured approaches
  • Those who can reliably take medication daily

Complementary Treatments

  • Combine disulfiram with counseling and behavioral therapy for optimal outcomes 2, 6
  • Brief motivational interventions should be routinely used alongside medication 2
  • Consider participation in mutual help groups like Alcoholics Anonymous 6

Cautions

  • Alcohol-disulfiram reactions can be severe and potentially life-threatening
  • The previously common practice of conducting a "trial reaction" with alcohol is now largely abandoned and should never be performed in patients over 50 years of age 1
  • Disulfiram has no proven effect on long-term alcoholism outcomes when used without accompanying education and counseling 3

Remember that disulfiram is only one component of a comprehensive alcoholism treatment plan, and its effectiveness depends heavily on patient compliance and concurrent psychosocial interventions.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Disulfiram treatment of alcoholism.

The American journal of medicine, 1990

Research

The clinical use of disulfiram (Antabuse): a review.

Journal of psychoactive drugs, 1988

Guideline

Management of Alcohol Dependence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.